ID: ALA4782738

Max Phase: Preclinical

Molecular Formula: C15H13FN4OS

Molecular Weight: 316.36

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(NC(=O)Nc1ccc2nnsc2c1)c1cccc(F)c1

Standard InChI:  InChI=1S/C15H13FN4OS/c1-9(10-3-2-4-11(16)7-10)17-15(21)18-12-5-6-13-14(8-12)22-20-19-13/h2-9H,1H3,(H2,17,18,21)

Standard InChI Key:  QHOWJTHABRGEON-UHFFFAOYSA-N

Associated Targets(Human)

Bromodomain adjacent to zinc finger domain protein 1A 48 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 316.36Molecular Weight (Monoisotopic): 316.0794AlogP: 3.71#Rotatable Bonds: 3
Polar Surface Area: 66.91Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.06CX Basic pKa: CX LogP: 3.46CX LogD: 3.46
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.77Np Likeness Score: -2.60

References

1. Yang Z,Zhou Y,Zhong L.  (2021)  Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation.,  33  [PMID:33333161] [10.1016/j.bmcl.2020.127745]

Source